Schistosoma japonicum infection induces macrophage polarization

Journal of Biomedical Research

Volumn 28, Issue 4, 2014, Pages 299-308

  Xu, Jingwei ^a   Zhang, Hao ^a   Chen, Lin ^a,b   Zhang, Donghui ^a,b   Ji, Minjun ^a,b   Wu, Haiwei ^a,b,c   Wu, Guanling ^a,b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Jiangsu Province Key Laboratory of Modern Pathogen Biology   (China)

^c RHODE ISLAND HOSPITAL   (United States)

Author keywords

Macrophage; Polarization; Schistosome japonicum; TLRs

Indexed keywords

ARGININE; CD16 ANTIGEN; CD32 ANTIGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE CULTURE; MACROPHAGE POLARIZATION; MICROENVIRONMENT; MOUSE; NONHUMAN; ONCOMELANIA HUPENSIS; PERITONEUM MACROPHAGE; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA;

EID: 84921885037     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.7555/JBR.27.20130072     Document Type: Article

References (34)

1. Jia TW, Zhou XN, Wang XH, Utzinger J, Steinmann P, Wu XH. Assessment of the age-specific disability weight of chronic schistosomiasis japonica. Bull World Health Organ 2007;85:458-65.
2. Ross AG, Bartley PB, Sleigh AC, Olds GR, Li Y, Williams GM, et al. Schistosomiasis. N Engl J Med 2002;346:1212-20.
3. Gryseels B, Polman K, Clerinx J, Kestens L. Human schistosomiasis. Lancet 2006.368:1106-18.
4. Doherty JF, Moody AH, Wright SG. Katayama fever: an acute manifestation of schistosomiasis. BMJ 1996;313: 1071-2.
5. Ross AG, Vickers D, Olds GR, Shah SM, McManus DP. Katayama syndrome. Lancet Infect Dis 2007;7: 218-24.
6. Pearce EJ, MacDonald AS. The immunobiology of schistosomiasis. Nat Rev Immunol 2002;2:499-511.
7. Ji MJ, Su C, Wu HW, Zhu X, Cai XP, Li CL, et al. Gene expression profile of CD4+ T cells reveals an interferon signaling suppression associated with progression of experimental Schistosoma japonicum infection. Cell Immunol 2003;224:55-62.
8. Ji MJ, Su C, Wang Y, Wu HW, Cai XP, Li GF, et al. Characterization of CD4+ T cell responses in mice infected with Schistosoma japonicum. Acta Biochim Biophys Sin (Shanghai) 2006;38:327-34.
9. Gordon S. Macrophage heterogeneity and tissue lipids. J Clin Invest 2007;117:89-93.
10. Mosser DM. The many faces of macrophage activation. J Leukoc Biol 2003;73:209-12.
11. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003;3:23-35.
12. Smith P, Walsh CM, Mangan NE, Fallon RE, Sayers JR, McKenzie AN, et al. Schistosoma mansoni worms induce anergy of T cells via selective up-regulation of programmed death ligand 1 on macrophages. J Immunol 2004;173:1240-8.
13. Mantovani A, Sica A, Locati M. Macrophage polarization comes of age. Immunity 2005;23:344-6.
14. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007;117:175-84.
15. Biswas SK, Gangi L, Paul S, Schioppa T, Saccani A, Sironi M, et al. A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). Blood 2006;107:2112-22.
16. Mantovani A, Sica A, Locati M. New vistas on macrophage differentiation and activation. Eur J Immunol 2007;37:14-6.
17. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L, et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007;447:1116-20.
18. Zhang X, Goncalves R, Mosser DM.The isolation and characterization of murine macrophages. Curr Protoc Immunol. 2008;Chapter 14:Unit 14.1.
19. Zhang M, Gao Y, Du X, Zhang D, Ji M, Wu G. Toll-like receptor (TLR) 2 and TLR4 deficiencies exert differential in vivo effects against Schistosoma japonicum. Parasite Immunol. 2011 Apr;33(4):199-209. doi: 10.1111/j.1365- 3024.2010.01265.x
20. Li K, Guo Q, Wang C, Chen M, Xu W, Xiong S. Comparative analysis of phenotypes of classically (M1) and alternatively (M2) activated macrophages CURRENT IMMUNOLOLGY 2008;28:177-183.
21. Murawski MR, Bowen GN, Cerny AM, Anderson LJ, Haynes LM, Tripp RA, et al. Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. J Virol 2009;83:1492-500.
22. Feng CG, Scanga CA, Collazo-Custodio CM, Cheever AW, Hieny S, Caspar P, et al. Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals. J Immunol 2003;171:4758-64.
23. Pearl JI, Ma T, Irani AR, Huang Z, Robinson WH, Smith RL, et al. Role of the Toll-like receptor pathway in the recognition of orthopedic implant wear-debris particles. Biomaterials 32:5535-42.
24. Gelani V, Fernandes AP, Gasparoto TH, Garlet TP, Cestari TM, Lima HR, et al. The role of toll-like receptor 2 in the recognition of Aggregatibacter actinomycetemcomitans. J Periodontol 2009;80:2010-9.
25. Fuse ET, Tateda K, Kikuchi Y, Matsumoto T, Gondaira F, Azuma A, et al. Role of Toll-like receptor 2 in recognition of Legionella pneumophila in a murine pneumonia model. J Med Microbiol 2007;56(Pt 3):305-12.
26. Mun HS, Aosai F, Norose K, Chen M, Piao LX, Takeuchi O, et al. TLR2 as an essential molecule for protective immunity against Toxoplasma gondii infection. Int Immunol 2003;15(9):1081-7.
27. Campos MA, Almeida IC, Takeuchi O, Akira S, Valente EP, Procopio DO, et al. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J Immunol 2001;167:416-23.
28. Oliveira AC, Peixoto JR, de Arruda LB, Campos MA, Gazzinelli RT, Golenbock DT, et al. Expression of functional TLR4 confers proinflammatory responsiveness to Trypanosoma cruzi glycoinositolphospholipids and higher resistance to infection with T. cruzi. J Immunol 2004;173: 5688-96.
29. Netea MG, Sutmuller R, Hermann C, Van der Graaf CA, Van der Meer JW, van Krieken JH, et al. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol 2004;172:3712-8.
30. Kurt-Jones EA, Chan M, Zhou S, Wang J, Reed G, Bronson R, et al. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci U S A 2004;101:1315-20.
31. Zhang M, Gao Y, Du X, Zhang D, Ji M, Wu G. Toll-like receptor (TLR) 2 and TLR4 deficiencies exert differential in vivo effects against Schistosoma japonicum. Parasite Immunol 33:199-209.
32. Cheng PC, Lin CN, Peng SY, Li LL, Luo TY, Fan CK, et al. A study of immunomodulatory genes responses to macrophages of Schistosoma japonicum infection during different stages by microarray analysis. Acta Trop 2013;127:251-260.
33. Porta C, Rimoldi M, Raes G, Brys L, Ghezzi P, Di Liberto D, et al. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc Natl Acad Sci U S A 2009; 106:14978-83.
34. Namangala B, Brys L, Magez S, De Baetselier P, Beschin A.Trypanosoma brucei brucei infection impairs MHC class antigen presentation capacity of macrophages. Parasite II Immunol 2000;22:361-70.